Skip to main content

Table 1 Patient and Tumor Characteristics.

From: The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

Characteristic N %
Total Patients 31 100%
Patient sex   
  Male 13 42%
  Women 18 58%
Primary Site   
  Non-small Cell Lung 9 16%
  Sarcoma 5 9%
  Breast 4 7%
  Head and Neck 4 7%
  Colon 4 7%
  Small Cell Lung 3 5%
  Basal Cell 1 2%
  Ovarian 1 2%
Metastatic Sites   
  Lung 19 33%
  Lymph Node 11 19%
  Osseous 11 19%
  Liver 9 16%
  Adrenal 6 10%
  Soft tissue 2 3%
Dose   
  24 Gray 19 33%
  30 Gray 20 35%
  36 Gray 8 14%
  42 Gray 9 16%
  50 Gray 2 3%